Pinnacle Private Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-6,309
Closed -$386K – 303
2021
Q4
$386K Buy
+6,309
New +$436K 0.12% 178

Other funds holding ARKG

Pinnacle Private Wealth's ARKG Position: Q1 2022 in Review

Pinnacle Private Wealth sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 6,309 shares — an estimated $386K sold.

Pinnacle Private Wealth first reported a position in ARKG in Q4 2021 and held it in 1 quarter. The position peaked at $386K in Q4 2021. 388 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Pinnacle Private Wealth reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Pinnacle Private Wealth sold 6,309 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $386K.
  • Pinnacle Private Wealth first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 1 quarter.
  • Pinnacle Private Wealth's ARK Genomic Revolution ETF position peaked at $386K in Q4 2021.
  • 388 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Pinnacle Private Wealth's 13F filing for Q1 2022, filed 29 Apr 2022.